Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1864 entries
Sorted by: Best Match Show Resources per page
Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: A report of two cases and review of the literature.

International journal of surgery case reports

Takiyama H, Kazama S, Tanoue Y, Yasuda K, Otani K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Miyagawa T, Yamada D, Yamaguchi H, Ishihara S, Sunami E, Watanabe T.
PMID: 26339787
Int J Surg Case Rep. 2015;15:107-11. doi: 10.1016/j.ijscr.2015.08.028. Epub 2015 Aug 20.

BACKGROUND: Perianal hidradenitis suppurativa (PHS) is a chronic recurrent inflammatory disease of the apocrine glands present in the skin and soft tissue adjacent to the anus. It is often misdiagnosed or treatment is delayed, resulting in the formation of...

Cite
Takiyama H, Kazama S, Tanoue Y, et al. Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: A report of two cases and review of the literature. Int J Surg Case Rep. 2015;15:107-11doi: 10.1016/j.ijscr.2015.08.028.
Takiyama, H., Kazama, S., Tanoue, Y., Yasuda, K., Otani, K., Nishikawa, T., Tanaka, T., Tanaka, J., Kiyomatsu, T., Hata, K., Kawai, K., Nozawa, H., Miyagawa, T., Yamada, D., Yamaguchi, H., Ishihara, S., Sunami, E., & Watanabe, T. (2015). Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: A report of two cases and review of the literature. International journal of surgery case reports, 15107-11. https://doi.org/10.1016/j.ijscr.2015.08.028
Takiyama, Hirotoshi, et al. "Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: A report of two cases and review of the literature." International journal of surgery case reports vol. 15 (2015): 107-11. doi: https://doi.org/10.1016/j.ijscr.2015.08.028
Takiyama H, Kazama S, Tanoue Y, Yasuda K, Otani K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Miyagawa T, Yamada D, Yamaguchi H, Ishihara S, Sunami E, Watanabe T. Efficacy of magnetic resonance imaging in the diagnosis of perianal hidradenitis suppurativa, complicated by anal fistulae: A report of two cases and review of the literature. Int J Surg Case Rep. 2015;15:107-11. doi: 10.1016/j.ijscr.2015.08.028. Epub 2015 Aug 20. PMID: 26339787; PMCID: PMC4601969.
Copy Download .nbib Format: NLM
Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia.

Journal of anesthesia

Nishikawa T, Tajima K, Kimura T, Satsumae T.
PMID: 28921086
J Anesth. 1996 Dec;10(4):248-251. doi: 10.1007/BF02483390.

Clonidine, an α

Cite
Nishikawa T, Tajima K, Kimura T, et al. Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia. J Anesth. 1996;10(4):248-251doi: 10.1007/BF02483390.
Nishikawa, T., Tajima, K., Kimura, T., & Satsumae, T. (1996). Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia. Journal of anesthesia, 10(4), 248-251. https://doi.org/10.1007/BF02483390
Nishikawa, Toshiaki, et al. "Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia." Journal of anesthesia vol. 10,4 (1996): 248-251. doi: https://doi.org/10.1007/BF02483390
Nishikawa T, Tajima K, Kimura T, Satsumae T. Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia. J Anesth. 1996 Dec;10(4):248-251. doi: 10.1007/BF02483390. PMID: 28921086.
Copy Download .nbib Format: NLM
Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.

Nature communications

Kishikawa T, Otsuka M, Yoshikawa T, Ohno M, Ijichi H, Koike K.
PMID: 27667193
Nat Commun. 2016 Sep 26;7:13006. doi: 10.1038/ncomms13006.

Highly repetitive tandem arrays at the centromeric and pericentromeric regions in chromosomes, previously considered silent, are actively transcribed, particularly in cancer. This aberrant expression occurs even in K-ras-mutated pancreatic intraepithelial neoplasia (PanIN) tissues, which are precancerous lesions. To examine...

Cite
Kishikawa T, Otsuka M, Yoshikawa T, et al. Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. Nat Commun. 2016;7:13006doi: 10.1038/ncomms13006.
Kishikawa, T., Otsuka, M., Yoshikawa, T., Ohno, M., Ijichi, H., & Koike, K. (2016). Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. Nature communications, 713006. https://doi.org/10.1038/ncomms13006
Kishikawa, Takahiro, et al. "Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1." Nature communications vol. 7 (2016): 13006. doi: https://doi.org/10.1038/ncomms13006
Kishikawa T, Otsuka M, Yoshikawa T, Ohno M, Ijichi H, Koike K. Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. Nat Commun. 2016 Sep 26;7:13006. doi: 10.1038/ncomms13006. PMID: 27667193; PMCID: PMC5052683.
Copy Download .nbib Format: NLM
A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine.

Clinical case reports

Umeda M, Kondo T, Nishikori M, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A.
PMID: 26783429
Clin Case Rep. 2015 Nov 09;4(1):23-5. doi: 10.1002/ccr3.436. eCollection 2016 Jan.

Currently, there is no standard treatment for neurolymphomatosis because of the scarcity of clinical studies. Here, we report the successful treatment of neurolymphomatosis caused by follicular lymphoma with bendamustine, which could be an effective treatment option for this condition.

Cite
Umeda M, Kondo T, Nishikori M, et al. A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clin Case Rep. 2015;4(1):23-5doi: 10.1002/ccr3.436.
Umeda, M., Kondo, T., Nishikori, M., Kitano, T., Hishizawa, M., Kadowaki, N., & Takaori-Kondo, A. (2016). A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clinical case reports, 4(1), 23-5. https://doi.org/10.1002/ccr3.436
Umeda, Masayuki, et al. "A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine." Clinical case reports vol. 4,1 (2016): 23-5. doi: https://doi.org/10.1002/ccr3.436
Umeda M, Kondo T, Nishikori M, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A. A case of neurolymphomatosis caused by follicular lymphoma successfully treated with bendamustine. Clin Case Rep. 2015 Nov 09;4(1):23-5. doi: 10.1002/ccr3.436. eCollection 2016 Jan. PMID: 26783429; PMCID: PMC4706405.
Copy Download .nbib Format: NLM
Oral cenesthopathy.

BioPsychoSocial medicine

Umezaki Y, Miura A, Watanabe M, Takenoshita M, Uezato A, Toriihara A, Nishikawa T, Toyofuku A.
PMID: 27293481
Biopsychosoc Med. 2016 Jun 10;10:20. doi: 10.1186/s13030-016-0071-7. eCollection 2016.

Cenesthopathy is characterized by abnormal and strange bodily sensations and is classified as a 'delusional disorder, somatic type' or 'somatoform disorder' according to the DSM 5. The oral cavity is one of the frequent sites of cenesthopathy, thus the...

Cite
Umezaki Y, Miura A, Watanabe M, et al. Oral cenesthopathy. Biopsychosoc Med. 2016;10:20doi: 10.1186/s13030-016-0071-7.
Umezaki, Y., Miura, A., Watanabe, M., Takenoshita, M., Uezato, A., Toriihara, A., Nishikawa, T., & Toyofuku, A. (2016). Oral cenesthopathy. BioPsychoSocial medicine, 1020. https://doi.org/10.1186/s13030-016-0071-7
Umezaki, Yojiro, et al. "Oral cenesthopathy." BioPsychoSocial medicine vol. 10 (2016): 20. doi: https://doi.org/10.1186/s13030-016-0071-7
Umezaki Y, Miura A, Watanabe M, Takenoshita M, Uezato A, Toriihara A, Nishikawa T, Toyofuku A. Oral cenesthopathy. Biopsychosoc Med. 2016 Jun 10;10:20. doi: 10.1186/s13030-016-0071-7. eCollection 2016. PMID: 27293481; PMCID: PMC4903001.
Copy Download .nbib Format: NLM
GaP Raman Terahertz high accuracy spectrometer and its application to detect organic and inorganic crystalline defects.

Proceedings of the Japan Academy. Series B, Physical and biological sciences

Nishizawa J, Suto K, Sasaki T, Tanabe T, Tanno T, Oyama Y, Sato F.
PMID: 25792796
Proc Jpn Acad Ser B Phys Biol Sci. 2006 Dec;82(9):353-8. doi: 10.2183/pjab.82.353. Epub 2006 Feb 12.

One of the most important uses of THz spectrometry is to detect defects in molecular structure or in crystals efficiently. We applied GaP Raman THz (GRT) spectrometer to detect and evaluate defects in inorganic and organic materials. High THz-wave...

Cite
Nishizawa J, Suto K, Sasaki T, et al. GaP Raman Terahertz high accuracy spectrometer and its application to detect organic and inorganic crystalline defects. Proc Jpn Acad Ser B Phys Biol Sci. 2006;82(9):353-8doi: 10.2183/pjab.82.353.
Nishizawa, J., Suto, K., Sasaki, T., Tanabe, T., Tanno, T., Oyama, Y., & Sato, F. (2006). GaP Raman Terahertz high accuracy spectrometer and its application to detect organic and inorganic crystalline defects. Proceedings of the Japan Academy. Series B, Physical and biological sciences, 82(9), 353-8. https://doi.org/10.2183/pjab.82.353
Nishizawa, Jun-Ichi, et al. "GaP Raman Terahertz high accuracy spectrometer and its application to detect organic and inorganic crystalline defects." Proceedings of the Japan Academy. Series B, Physical and biological sciences vol. 82,9 (2006): 353-8. doi: https://doi.org/10.2183/pjab.82.353
Nishizawa J, Suto K, Sasaki T, Tanabe T, Tanno T, Oyama Y, Sato F. GaP Raman Terahertz high accuracy spectrometer and its application to detect organic and inorganic crystalline defects. Proc Jpn Acad Ser B Phys Biol Sci. 2006 Dec;82(9):353-8. doi: 10.2183/pjab.82.353. Epub 2006 Feb 12. PMID: 25792796; PMCID: PMC4338840.
Copy Download .nbib Format: NLM
A Case of Fulminant Myocarditis With Preceding Repeated Episodes of Congestive Heart Failure.

Cardiology research

Tada Y, Uto K, Wada H, Sakakura KI, Suzuki JI, Nishikawa T, Ako J, Momomura SI.
PMID: 28352425
Cardiol Res. 2013 Apr;4(2):78-81. doi: 10.4021/cr261w. Epub 2013 May 09.

We report a rare case of fulminant myocarditis that was considered to have smoldered for a few months before it finally exteriorized. An 80-year-old man had had two episodes of mild congestive heart failure with preserved ejection function (HFPEF)...

Cite
Tada Y, Uto K, Wada H, et al. A Case of Fulminant Myocarditis With Preceding Repeated Episodes of Congestive Heart Failure. Cardiol Res. 2013;4(2):78-81doi: 10.4021/cr261w.
Tada, Y., Uto, K., Wada, H., Sakakura, K. I., Suzuki, J. I., Nishikawa, T., Ako, J., & Momomura, S. I. (2013). A Case of Fulminant Myocarditis With Preceding Repeated Episodes of Congestive Heart Failure. Cardiology research, 4(2), 78-81. https://doi.org/10.4021/cr261w
Tada, Yuko, et al. "A Case of Fulminant Myocarditis With Preceding Repeated Episodes of Congestive Heart Failure." Cardiology research vol. 4,2 (2013): 78-81. doi: https://doi.org/10.4021/cr261w
Tada Y, Uto K, Wada H, Sakakura KI, Suzuki JI, Nishikawa T, Ako J, Momomura SI. A Case of Fulminant Myocarditis With Preceding Repeated Episodes of Congestive Heart Failure. Cardiol Res. 2013 Apr;4(2):78-81. doi: 10.4021/cr261w. Epub 2013 May 09. PMID: 28352425; PMCID: PMC5358218.
Copy Download .nbib Format: NLM
Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy.

Journal of diabetes investigation

Nishikawa T, Brownlee M, Araki E.
PMID: 25802720
J Diabetes Investig. 2015 Mar;6(2):137-9. doi: 10.1111/jdi.12258. Epub 2014 Jul 25.

No abstract available.

Cite
Nishikawa T, Brownlee M, Araki E. Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy. J Diabetes Investig. 2014;6(2):137-9doi: 10.1111/jdi.12258.
Nishikawa, T., Brownlee, M., & Araki, E. (2015). Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy. Journal of diabetes investigation, 6(2), 137-9. https://doi.org/10.1111/jdi.12258
Nishikawa, Takeshi, et al. "Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy." Journal of diabetes investigation vol. 6,2 (2015): 137-9. doi: https://doi.org/10.1111/jdi.12258
Nishikawa T, Brownlee M, Araki E. Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy. J Diabetes Investig. 2015 Mar;6(2):137-9. doi: 10.1111/jdi.12258. Epub 2014 Jul 25. PMID: 25802720; PMCID: PMC4364847.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
DIFFERENCES IN THE PRODUCTION AND EXCRETION KINETICS OF OKADAIC ACID, DINOPHYSISTOXIN-1, AND PECTENOTOXIN-2 BETWEEN CULTURES OF DINOPHYSIS ACUMINATA AND DINOPHYSIS FORTII ISOLATED FROM WESTERN JAPAN(1).

Journal of phycology

Nagai S, Suzuki T, Nishikawa T, Kamiyama T.
PMID: 27020356
J Phycol. 2011 Dec;47(6):1326-37. doi: 10.1111/j.1529-8817.2011.01076.x. Epub 2011 Nov 04.

We established clonal cultures of Dinophysis acuminata Clap. et Lachm. and D. fortii Pavill. isolated from western Japan and examined toxin production in them, focusing on intracellular production and extracellular excretion. At the end of incubations, the total amounts...

Cite
Nagai S, Suzuki T, Nishikawa T, et al. DIFFERENCES IN THE PRODUCTION AND EXCRETION KINETICS OF OKADAIC ACID, DINOPHYSISTOXIN-1, AND PECTENOTOXIN-2 BETWEEN CULTURES OF DINOPHYSIS ACUMINATA AND DINOPHYSIS FORTII ISOLATED FROM WESTERN JAPAN(1). J Phycol. 2011;47(6):1326-37doi: 10.1111/j.1529-8817.2011.01076.x.
Nagai, S., Suzuki, T., Nishikawa, T., & Kamiyama, T. (2011). DIFFERENCES IN THE PRODUCTION AND EXCRETION KINETICS OF OKADAIC ACID, DINOPHYSISTOXIN-1, AND PECTENOTOXIN-2 BETWEEN CULTURES OF DINOPHYSIS ACUMINATA AND DINOPHYSIS FORTII ISOLATED FROM WESTERN JAPAN(1). Journal of phycology, 47(6), 1326-37. https://doi.org/10.1111/j.1529-8817.2011.01076.x
Nagai, Satoshi, et al. "DIFFERENCES IN THE PRODUCTION AND EXCRETION KINETICS OF OKADAIC ACID, DINOPHYSISTOXIN-1, AND PECTENOTOXIN-2 BETWEEN CULTURES OF DINOPHYSIS ACUMINATA AND DINOPHYSIS FORTII ISOLATED FROM WESTERN JAPAN(1)." Journal of phycology vol. 47,6 (2011): 1326-37. doi: https://doi.org/10.1111/j.1529-8817.2011.01076.x
Nagai S, Suzuki T, Nishikawa T, Kamiyama T. DIFFERENCES IN THE PRODUCTION AND EXCRETION KINETICS OF OKADAIC ACID, DINOPHYSISTOXIN-1, AND PECTENOTOXIN-2 BETWEEN CULTURES OF DINOPHYSIS ACUMINATA AND DINOPHYSIS FORTII ISOLATED FROM WESTERN JAPAN(1). J Phycol. 2011 Dec;47(6):1326-37. doi: 10.1111/j.1529-8817.2011.01076.x. Epub 2011 Nov 04. PMID: 27020356.
Copy Download .nbib Format: NLM
Anti-prion activity found in beetle grub hemolymph of .

Biochemistry and biophysics reports

Hamanaka T, Nishizawa K, Sakasegawa Y, Kurahashi H, Oguma A, Teruya K, Doh-Ura K.
PMID: 29124167
Biochem Biophys Rep. 2015 Jul 17;3:32-37. doi: 10.1016/j.bbrep.2015.07.009. eCollection 2015 Sep.

No remedies for prion disease have been established, and the conversion of normal to abnormal prion protein, a key event in prion disease, is still unclear. Here we found that substances in beetle grub hemolymph, after they were browned...

Cite
Hamanaka T, Nishizawa K, Sakasegawa Y, et al. Anti-prion activity found in beetle grub hemolymph of . Biochem Biophys Rep. 2015;3:32-37doi: 10.1016/j.bbrep.2015.07.009.
Hamanaka, T., Nishizawa, K., Sakasegawa, Y., Kurahashi, H., Oguma, A., Teruya, K., & Doh-Ura, K. (2015). Anti-prion activity found in beetle grub hemolymph of . Biochemistry and biophysics reports, 332-37. https://doi.org/10.1016/j.bbrep.2015.07.009
Hamanaka, Taichi, et al. "Anti-prion activity found in beetle grub hemolymph of ." Biochemistry and biophysics reports vol. 3 (2015): 32-37. doi: https://doi.org/10.1016/j.bbrep.2015.07.009
Hamanaka T, Nishizawa K, Sakasegawa Y, Kurahashi H, Oguma A, Teruya K, Doh-Ura K. Anti-prion activity found in beetle grub hemolymph of . Biochem Biophys Rep. 2015 Jul 17;3:32-37. doi: 10.1016/j.bbrep.2015.07.009. eCollection 2015 Sep. PMID: 29124167; PMCID: PMC5668675.
Copy Download .nbib Format: NLM
A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report.

Journal of thoracic disease

Shiroyama T, Tamiya M, Hayama M, Nishihara T, Nishida T, Tanaka A, Morishita N, Suzuki H, Okamoto N, Kawahara K, Hirashima T.
PMID: 27162697
J Thorac Dis. 2016 May;8(5):E345-8. doi: 10.21037/jtd.2016.03.43.

An 87-year-old man with postoperative recurrent lung adenocarcinoma was treated with gefitinib. At the beginning of treatment, surgically resected archived tumor tissue revealed a deletion in exon 19 of the EGFR gene, but no ALK gene rearrangement. After gefitinib...

Cite
Shiroyama T, Tamiya M, Hayama M, et al. A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report. J Thorac Dis. 2016;8(5):E345-8doi: 10.21037/jtd.2016.03.43.
Shiroyama, T., Tamiya, M., Hayama, M., Nishihara, T., Nishida, T., Tanaka, A., Morishita, N., Suzuki, H., Okamoto, N., Kawahara, K., & Hirashima, T. (2016). A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report. Journal of thoracic disease, 8(5), E345-8. https://doi.org/10.21037/jtd.2016.03.43
Shiroyama, Takayuki, et al. "A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report." Journal of thoracic disease vol. 8,5 (2016): E345-8. doi: https://doi.org/10.21037/jtd.2016.03.43
Shiroyama T, Tamiya M, Hayama M, Nishihara T, Nishida T, Tanaka A, Morishita N, Suzuki H, Okamoto N, Kawahara K, Hirashima T. A heterochronic genetic change from an EGFR mutation to an ALK rearrangement in a patient with lung adenocarcinoma: a case report. J Thorac Dis. 2016 May;8(5):E345-8. doi: 10.21037/jtd.2016.03.43. PMID: 27162697; PMCID: PMC4842787.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1864 entries